Long-term cardiovascular morbidity and mortality in Turner syndrome patients with congenital heart disease: a single-center retrospective cohort study.
Oct 2026· International Journal of Cardiology· pp.
134964
· 0 citations· 20 references
Medicine
TL;DR
Despite generally favorable functional status among survivors, progressive valve dysfunction, aortic complications and cardiovascular mortality support lifelong structured surveillance.
Abstract
Objective
Congenital cardiac anomalies are a major determinant of morbidity and mortality in Turner syndrome (TS), yet long-term cardiovascular outcome data remain limited. This study assessed cardiovascular morbidity, mortality, valve dysfunction, and aortic outcomes in TS patients with congenital cardiovascular defects.
Methods
In this single-center retrospective cohort study, 84 TS patients with congenital cardiovascular anomalies were analyzed, with follow-up between 01/1980 and 01/2025. Clinical, demographic, electrocardiographic and echocardiographic variables were reviewed; morbidity and mortality were recorded; descriptive statistics applied.
Results
Bicuspid aortic valve (BAV) was present in 40 patients (48%) and coarctation of the aorta (CoA) in 29 (35%); 19 patients (23%) had both. At last follow-up (median age 26 years, IQR 31 years), most patients were in NYHA class I (82%) and mean systolic and diastolic blood pressure were 121.7 ± 16.8 mmHg and 76.1 ± 13.1 mmHg, respectively. Sinus rhythm was present in 96% of the patients. In the BAV cohort, aortic regurgitation increased from 6 patients (15%) at first registration to 17 (42.5%) at last follow-up. In the tricuspid aortic valve cohort, aortic regurgitation increased from 1 patient (2.3%) to 12 (27.9%). The last mean ascending aortic diameter indexed to body surface area was 20.4 ± 4.6 mm/m2. Aortic dissection occurred in 2 patients (2.7%). Ten patients died during follow-up; median age at death was 41 years (IQR: 52 years), and cardiac causes accounted for at least 50% of mortality.
Conclusion
BAV and CoA predominated in this TS cohort. Despite generally favorable functional status among survivors, progressive valve dysfunction, aortic complications and cardiovascular mortality support lifelong structured surveillance.
Objective: Congenital heart diseases (CHDs) include congenital structural and functional abnormalities of the cardiovascular system and are associated with a high risk of mortality and morbidity. To evaluate early outcomes in infants with congenital heart disease (CHD), with a particular focus on critical CHD (CCHD), a...
M. Kasap Cuceoglu, Özge Altun Köroğlu, F. Ergin et al.· Ümraniye Pediatri Dergisi -...· 0 citations
The Fontan procedure provides favorable long - term outcomes; however, late complications remain significant; however, Lifelong surveillance is essential for optimal management.
Dac Dai Tran, Thi Thu Phuong Nghiem, Thi Hoai Thu Doan et al.· Tạp chí Phẫu thuật Tim mạch...· 0 citations
PurposeTo characterize the clinical characteristics, surgical experience, and long-term outcomes of patients with Kabuki syndrome (KS) and congenital heart disease (CHD).MethodsWe performed a retrospective single-center review of 37 pediatric patients with KS evaluated between January 2000 and January 2025. Among these...
M. Camacho, C. Yerebakan, Patrick McConnell et al.· World journal for pediatric...· 0 citations
Background/Objectives: Coarctation of the aorta (CoA) is associated with lifelong risks of residual or recurrent arch obstruction, hypertension, ventricular remodeling, and aortic-valve disease. We characterized documented morbidity and procedure-entry burden in a nationwide CoA registry cohort and assessed recurring m...
Paul C. Helm, Antonia Schulz, C. Niessner et al.· Medical Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.